Seroprevalence of hepatitis A and E virus infections among healthy population in shiraz, southern Iran

Jundishapur Journal of Microbiology

Volumn 8, Issue 7, 2015, Pages

  Asaei, Sadaf ^a   Ziyaeyan, Mazyar ^a   Moeini, Mahsa ^a   Jamalidoust, Marzieh ^a,b   Behzadi, Mohammad Amin ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Hepatitis A Virus; Hepatitis E Virus; Iran; Seroepidemiological Study

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE;

HEPATITIS A VIRUS; HEPATITIS E VIRUS;

EID: 84937850207     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.19311v2     Document Type: Article

References (25)

1. Costa-Mattioli M, Di Napoli A, Ferre V, Billaudel S, Perez-Bercoff R, Cristina J. Genetic variability of hepatitis A virus. J Gen Virol. 2003;84(Pt 12):3191–201.
2. Yong HT, Son R. Hepatitis A virus. Int Food Res J. 2009;16:455–67.
3. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepidemiology of hepatitis a in the croatian population. Hepat Mon. 2011;11(12):997–9.
4. Vancelik S, Guraksin A, Alp H. Hepatitis A seroepidemiology in Eastern Turkey. East Afr Med J. 2006;83(2):86–90.
5. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of hepatitis A in Korea: changes over the past 30 years. J Korean Med Sci. 2011;26(6):791–6.
6. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362(9381):371–3.
7. Chandra V, Taneja S, Kalia M, Jameel S. Molecular biology and pathogenesis of hepatitis E virus. J Biosci. 2008;33(4):451–64.
8. Ghorbani GA, Alavian SM, Esfahani AA, Assari S. Seroepidemiology of Hepatitis E Virus in Iranian Soldiers. Hepat mon. 2007;7(3):123–6.
9. Sepanlou S, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S. A Population-based Seroepidemiological Study on Hepatitis E Virus in Iran. Middle East J Dig Dis. 2010;2(2):97–103.
10. Livni G, Plotkin S, Yuhas Y, Chodik G, Aloni H, Lerman Y, et al. Seroepidemiology of hepatitis A antibodies among children's hospital staff. Pediatr Infect Dis J. 2002;21(7):618–22.
11. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247(4948):1335–9.
12. Ungan M, Yaman H, Taheri N. The seroprevalence of specific antibodies to hepatitis A virus in a Turkish population. Eur J Gastroenterol Hepatol. 2002;14(9):1033–4.
13. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285–8.
14. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010;13(2):99–104.
15. Traore KA, Rouamba H, Nebie Y, Sanou M, Traore AS, Barro N, et al. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso. PLoS One. 2012;7(10):e48125.
16. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012;106(9):528–31.
17. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a populationbased study. Int J Infect Dis. 2009;13(1):67–71.
18. Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR. Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2008;14(1):157–62.
19. Zali MR, Taremi M, Arantibodiesi S, Ardalan A, Alizadeh AHM, Ansari S. Seroprevalence of hepatitis E in Nahavand, Iran: Apopulation-based study. East Mediterr Health J. 2008;14(1):157–62.
20. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012;367(13):1237–44.
21. Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130(4):1129–34.
22. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008;28(9):1190–9.
23. Larry K, Carol JB, David WK, Sarah SL. Red Book. 28 edAmerica: American Academy of pediatrics; 2009.
24. Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis. 1995;171 Suppl 1:S15–8.
25. Panda SK, Thakral D, Rehman S. Hepatitis E virus. Rev Med Virol. 2007;17(3):151–80.